Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 USD | +6.57% | +31.98% | +29.71% |
Financials (USD)
Sales 2024 * | 3.4M | Sales 2025 * | 4.28M | Capitalization | 9.71M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -22M | EV / Sales 2024 * | 2.85 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
-0.99
x | P/E ratio 2025 * |
-1.21
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.77% |
Latest transcript on Plus Therapeutics, Inc.
1 day | +6.57% | ||
1 week | +31.98% | ||
Current month | +30.42% | ||
1 month | +20.11% | ||
3 months | +12.94% | ||
6 months | +42.77% | ||
Current year | +29.71% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 20-02-05 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Richard Hawkins
CHM | Chairman | 75 | 07-11-30 |
Robert Lenk
BRD | Director/Board Member | 75 | 20-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2.27 | +6.57% | 234,886 |
24-05-07 | 2.13 | +5.97% | 138,887 |
24-05-06 | 2.01 | +11.67% | 2,136,899 |
24-05-03 | 1.8 | 0.00% | 3,705 |
24-05-02 | 1.8 | +4.65% | 51,657 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.71% | 9.71M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- PSTV Stock